HUP0203884A3 - Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics and pharmaceutical compositions containing them - Google Patents

Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics and pharmaceutical compositions containing them

Info

Publication number
HUP0203884A3
HUP0203884A3 HU0203884A HUP0203884A HUP0203884A3 HU P0203884 A3 HUP0203884 A3 HU P0203884A3 HU 0203884 A HU0203884 A HU 0203884A HU P0203884 A HUP0203884 A HU P0203884A HU P0203884 A3 HUP0203884 A3 HU P0203884A3
Authority
HU
Hungary
Prior art keywords
antidiabetics
crystals
pharmaceutical compositions
compositions containing
acid derivative
Prior art date
Application number
HU0203884A
Other languages
English (en)
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of HUP0203884A2 publication Critical patent/HUP0203884A2/hu
Publication of HUP0203884A3 publication Critical patent/HUP0203884A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU0203884A 1999-10-29 2000-10-26 Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics and pharmaceutical compositions containing them HUP0203884A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30834699 1999-10-29
PCT/JP2000/007482 WO2001032637A1 (en) 1999-10-29 2000-10-26 Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics

Publications (2)

Publication Number Publication Date
HUP0203884A2 HUP0203884A2 (hu) 2003-03-28
HUP0203884A3 true HUP0203884A3 (en) 2005-01-28

Family

ID=17979966

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0203884A HUP0203884A3 (en) 1999-10-29 2000-10-26 Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics and pharmaceutical compositions containing them

Country Status (19)

Country Link
US (1) US6777435B1 (hu)
EP (1) EP1224178B1 (hu)
KR (1) KR100433885B1 (hu)
CN (1) CN1407975A (hu)
AR (1) AR031078A1 (hu)
AT (1) ATE243684T1 (hu)
AU (1) AU7958100A (hu)
CA (1) CA2388200A1 (hu)
CL (1) CL2000002938A1 (hu)
CO (1) CO5261530A1 (hu)
DE (1) DE60003577T2 (hu)
HK (1) HK1044536A1 (hu)
HU (1) HUP0203884A3 (hu)
MY (1) MY135840A (hu)
NO (1) NO20022007L (hu)
PE (1) PE20010761A1 (hu)
PL (1) PL364171A1 (hu)
TW (1) TW558554B (hu)
WO (1) WO2001032637A1 (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2403903A1 (en) * 2000-03-28 2002-09-26 Masatoshi Hazama Angiogenesis inhibitors
JP4590159B2 (ja) 2001-04-04 2010-12-01 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド グルコース再吸収阻害剤およびｐｐａｒモジュレーターを含んで成る併用療法
ATE442148T1 (de) * 2001-04-04 2009-09-15 Ortho Mcneil Janssen Pharm Kombinationstherapie durch glukoseresorptionshemmer und retinoid x rezeptorenmodulatoren
CA2448741C (en) 2001-05-30 2010-06-22 Kissei Pharmaceutical Co., Ltd. Glucopyranosyloxypyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate therefor
TWI327462B (en) * 2002-01-18 2010-07-21 Sumitomo Chemical Co Condensed heterocyclic sulfonyl urea compound, a herbicide containing the same, and a method for weed control using the same
AU2003242396A1 (en) 2002-05-24 2003-12-12 Takeda Pharmaceutical Company Limited Insulin resistance improving agents
AU2005289808B2 (en) * 2004-09-24 2011-11-03 The Government Of The United States As Represented By The Secretary Of The Army, U.S. Army Medical Research Institute Of Chemical Defense Method of treating organophosphorous poisoning
US9132135B2 (en) * 2004-09-24 2015-09-15 University Of Maryland, Baltimore Method of treating organophosphorous poisoning
WO2007028394A2 (en) * 2005-09-08 2007-03-15 Gastrotech Pharma A/S Use of a glp-1 molecule for treatment of biliary dyskinesia and/or biliary pain/discomfort
TW201138843A (en) 2009-12-18 2011-11-16 Colgate Palmolive Co Biguanide preservation of precipitated calcium carbonate
US11191755B2 (en) 2014-01-17 2021-12-07 Cornell University Compositions and methods for providing cardioprotective effects
EP3094380B1 (en) * 2014-01-17 2021-04-28 Cornell University Methods of treating metabolic syndrome related conditions using retinoic acid receptor agonists
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
KR102281228B1 (ko) 2019-09-03 2021-07-22 신창수 과수나무의 가지지지용 파이프클램프

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69919156T2 (de) * 1998-05-11 2005-11-03 Takeda Pharmaceutical Co. Ltd. Oxyiminoalkansäure derivate mit hypoglykämischer und hypolipidemischer wirkung
CN1407969A (zh) * 1999-10-29 2003-04-02 武田药品工业株式会社 氧亚氨基链烷酸衍生物的制备方法

Also Published As

Publication number Publication date
ATE243684T1 (de) 2003-07-15
CA2388200A1 (en) 2001-05-21
MY135840A (en) 2008-07-31
DE60003577D1 (de) 2003-07-31
TW558554B (en) 2003-10-21
US6777435B1 (en) 2004-08-17
CO5261530A1 (es) 2003-03-31
HK1044536A1 (en) 2002-10-25
EP1224178A1 (en) 2002-07-24
CN1407975A (zh) 2003-04-02
AR031078A1 (es) 2003-09-10
DE60003577T2 (de) 2004-04-29
HUP0203884A2 (hu) 2003-03-28
CL2000002938A1 (es) 2009-05-15
EP1224178B1 (en) 2003-06-25
NO20022007D0 (no) 2002-04-26
AU7958100A (en) 2001-05-14
PE20010761A1 (es) 2001-08-01
KR100433885B1 (ko) 2004-06-04
PL364171A1 (en) 2004-12-13
KR20010102429A (ko) 2001-11-15
NO20022007L (no) 2002-06-24
WO2001032637A1 (en) 2001-05-10

Similar Documents

Publication Publication Date Title
IL145789A0 (en) Derivatives of propionic acid, their preparation and pharmaceutical compositions containing them
HUP0100819A3 (en) Aminophenoxyacetic acid derivatives as neuroprotectants and pharmaceutical compositions containing them
IL147217A0 (en) New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain
AU1307299A (en) Stable pharmaceutical compositions including ascorbic acid and methods of using same
IL127955A0 (en) Pharmaceutical composition containing acid addition salt of basic drug
HUP0203971A3 (en) Imidazoimidazoles and triazoles as anti-inflammatory agents and pharmaceutical compositions containing them and their use
HUP0200863A3 (en) Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them and their use
HUP0001471A2 (en) Pharmaceutical compositions containing amoxicilline and clavulanic acid potassium salt
HUP0204143A3 (en) Tricyclic 1-benzylpyrazole-3-carboxylic acid derivatives, preparation of the compounds, their use and pharmaceutical compositions containing them
IL164699A (en) Derivatives of diketohydrazine compounds and pharmaceutical compositions and medicaments containing the compounds as the active ingredient
HUP0002037A3 (en) Hydroximic acid derivatives, use of them for producing pharmaceutical compositions suitable for inhibiting matrix metalloproteinas and pharmaceutical compositions containing the compounds
HUP0002517A3 (en) Derivatives of acyl-piperazinil-pyrimidins, preparation thereof, pharmaceutical compositions containing them and their use as medicaments
HUP0004096A3 (en) Aggregates of human insulin derivatives and pharmaceutical compositions comprising thereof
HUP9903216A3 (en) Substituted benzamide and use of them as active ingredient in pharmaceutical compositions
HUP0203884A3 (en) Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics and pharmaceutical compositions containing them
IL115072A0 (en) Substituted 4-phenyl-6-amino-nicotinic acid derivatives their preparation pharmaceutical compositions containing them and their use
EP1311477A4 (en) NEW THIOCARBAMIDIC ACID DERIVATIVES AND MEDICAMENTS CONTAINING THEM
HUP0201846A3 (en) Amonobenzophenones as inhibitors of il-1betha and tnf-alpha and pharmaceutical compositions containing them
HUP0203431A3 (en) Novel heterocyclic compounds and salts thereof and pharmaceutical compositions containing and use of the same
HUP0105204A3 (en) Substituted phenethylamine derivatives and pharmaceutical compositions containing them
AP2001002355A0 (en) Derivatives of purine their preparation process and pharmaceutical compositions containing them
HUP0300402A3 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them
IL163959A (en) Derivatives of phenyl-sulfonylamino- benzoic acid and pharmaceutical compositions comprising them
HUP0001061A3 (en) Naphthylsulfonic acid derivatives and pharmaceutical compositions containing them
HUP0203270A3 (en) Hydroxamic acid derivative as inhibitor of the formation of human cd23, process for its preparation and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees